drugset / Trial / NCT00657241
Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril
RandomizedCrossoverSingle-blindTreatment
Summary
14-week single blind, double baseline, forced-titration, cross-over comparison of the cardiac benefits of Coreg CR compared to valsartan added to existing ACE inhibition
Timeline
- Start
- 2008-04
- Primary completion
- 2010-04
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Carvedilol | Other / unclassified | 40 mg | — |
| Comparator | Valsartan | Small molecule | 320 mg | — |